The Department of Laboratory Animal Resources (DLAR) is responsible for laboratory animal care and use for 50 peer review funded PIs of Roswell Park Cancer Institute (RPCI). This resource provides specialized animal husbandry, veterinary medical care, animal health surveillance, diagnostic laboratory facilities, many research technical services and resources including genetically-defined mice, a surgical program and technician and faculty training in support of the > 150 IACUC-approved animal use protocols. Additional resource services include polyclonal antibody production in several species, inbred and immune-deficient rodent production. Additional resource services include polyclonal antibody production in several species, inbred and immune-deficient rodent production. Daily animal inventories, currently about 15,000 include a variety of rodent species, rabbits, dogs and farm animals. The Department has 40 members, 100 of whom have achieved certification through the animal Technician Certification Board (ATCB) of the American Association for Laboratory Animal Science (AALAS). The new, four-story 41,000 nsf vivarium is within the new MRC that bridges Carlton Street and is between the Cancer Cell Center with its animal resource and the Research Studies Center. The combination of the two animal holding units provides >52,000 nsf. All mice housed in the new resource are viral antibody free. The basis for the mouse husbandry program is individually ventilated microisolators. Racks are designed too house 108 cages, each ventilated with sterile air and equipped port access with a continuous supply of purified water. A portion of the resource has been designed for ABSL, 2/3 capability for use with rodents. Labs for work with gene knockout and transgenic technologies in mice are immediately adjacent to animal holding rooms. The contiguous Cancer Center Animal Resource is the site of the new 4.7 Tesla CCSG animal research MRI resource and a whole animal cesium irradiation unit. The operating budget is comprised of revenues from institutional sources (74%), chargebacks (13%) and the Cancer Center Support Grant (13%). Continued support through the CCSG will permit DLAR to prove standard of care. and use that meet or exceed applicable state and federal standards, accomplish pursuit of DLAR to prove standard of care and use that meet or exceed applicable state and federal standards, accomplish pursuit of external accreditation (AALACi) and furnish investigators with a comprehensive program for safe, appropriate and cost effective research animal use.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA016056-26S1
Application #
6588803
Study Section
Project Start
2002-05-01
Project End
2003-04-30
Budget Start
Budget End
Support Year
26
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Wang, Xue; Niu, Jin; Li, Jun et al. (2018) Temporal Effects of Combined Birinapant and Paclitaxel on Pancreatic Cancer Cells Investigated via Large-Scale, Ion-Current-Based Quantitative Proteomics (IonStar). Mol Cell Proteomics 17:655-671
Burkard-Mandel, Lauren; O'Neill, Rachel; Colligan, Sean et al. (2018) Tumor-derived thymic stromal lymphopoietin enhances lung metastasis through an alveolar macrophage-dependent mechanism. Oncoimmunology 7:e1419115
Rosario, S R; Long, M D; Affronti, H C et al. (2018) Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas. Nat Commun 9:5330
Tsuji, Takemasa; Yoneda, Akira; Matsuzaki, Junko et al. (2018) Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy. Cancer Immunol Res 6:594-604
Narayanan, Sumana; Kawaguchi, Tsutomu; Yan, Li et al. (2018) Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer. Ann Surg Oncol 25:2323-2331
Ratajczak, Alexsandra; Feleszko, Wojciech; Smith, Danielle M et al. (2018) How close are we to definitively identifying the respiratory health effects of e-cigarettes? Expert Rev Respir Med 12:549-556
Terakawa, Tomoaki; Katsuta, Eriko; Yan, Li et al. (2018) High expression of SLCO2B1 is associated with prostate cancer recurrence after radical prostatectomy. Oncotarget 9:14207-14218
Zhu, Qianqian; Yan, Li; Liu, Qian et al. (2018) Exome chip analyses identify genes affecting mortality after HLA-matched unrelated-donor blood and marrow transplantation. Blood 131:2490-2499
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Li, Yanchun; Opyrchal, Mateusz; Yao, Song et al. (2018) The role of programmed death ligand-1 and tumor-infiltrating lymphocytes in breast cancer overexpressing HER2 gene. Breast Cancer Res Treat 170:293-302

Showing the most recent 10 out of 1555 publications